Sort   by:  
 Page size 
ProteomicsPolydopamine nanoparticles-based hyperthermal chemotherapy for the treatment of liver cancer
Polydopamine (PDA) is a polymer obtained from the self-polymerization of dopamine monomers; during the synthesis process, spherical nanoparticles are formed (PDA NPs), presenting several interesting properties such as high drug encapsulation capacity, easy and versatile surface modification, ability...
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD051299 | Pride
Hyperthermia Homotypic targeting Polydopamine nanoparticles Sorafenib 
ProteomicsIn vitro pilot study of polydopamine nanoparticles as protective antioxidant agents on fibroblasts cells derived from ARSACS patients
Reactive oxygen species (ROS) are active molecules involved in several biological functions. When the production of ROS is not counterbalanced by the action of protective antioxidant mechanisms present in living organisms, a condition of oxidative stress can arise with consequent damage to biologica...
ORGANISM(S): Homo sapiens (Human) 
2022-06-22 | PXD032916 | Pride
Reactive oxygen species Arsacs Polydopamine nanoparticles Fibroblasts 
GenomicsControlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles
Controlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles
PRJNA1035764 | ENA
UnknownOsteoclast-Driven Polydopamine-to-Dopamine Release: An Upgrade Patch for Polydopamine-Functionalized Tissue Engineering Scaffolds.
Not available
S-EPMC11355103 | biostudies-literature
ProteomicsPolydopamine nanoparticles (PDNPs) to remotely modulate the activity of differentiated SH-SY5Y cells and differentiated C2C12 cells
The precise control of cell activity is crucial for understanding and potentially treating many disorders. Focusing on neurons and myotubes, recent advancements in nanotechnology have introduced photoresponsive nanoparticles as a novel tool for modulating cell function with high spatial and temporal...
ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human) 
2025-04-23 | PXD061533 | Pride
Neurons Polydopamine Nir Nanoparticles 
ProteomicsPolydopamine nanoparticles as a potential pharmaceutical tool in the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD), or hepatic steatosis, has become one of the most common pathologies among liver-related disorders. The rapid accumulation of fat in this organ, and the consequent increment in oxidative stress levels, have been recognized as one of the main factors involved...
ORGANISM(S): Homo sapiens (Human) 
2024-10-02 | PXD046524 | Pride
Polydopamine nanoparticles  non-alcoholic fatty liver disease  antioxidants  hepatic steatosis 
TranscriptomicsControlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles
In the present study, we designed a nanoscale platform for the sustained and controlled delivery of nutrients to pancreatic islets-upon transplantation. Our platform consists of a mesoporous silica nanoparticle (MSNP), loaded with glutamine (G), an essential amino acid required for islet survival an...
ORGANISM(S): Mus musculus 
2023-12-04 | GSE247020 | GEO
UnknownNew insights in polydopamine formation via surface adsorption.
Not available
S-EPMC9905603 | biostudies-literature
UnknownUntemplated Resveratrol-Mediated Polydopamine Nanocapsule Formation.
Not available
S-EPMC6320237 | biostudies-literature
UnknownPolydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.
Not available
S-EPMC6315732 | biostudies-literature
Sort   by:  
 Page size